Combination of active agents for oral administration for improving the quality of nails
US9682025B2 · kind B2 · utility
0Cited by
7References
18Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 6, 2014 |
| Grant date | Jun 20, 2017 |
| Priority date | — |
| Expiry date | May 6, 2034 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K2800/92
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to the cosmetic use, by oral administration, of a combination of active agents including at least petroselinic acid and at least one active agent selected from among taurine, arginine, cysteine, zinc, a salt thereof, and lycopene, for improving the quality of nails, specifically the microvascularization of the nails, in particular in pre-hypertensive individuals.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.